Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS

Clinical trial NCT00467610 · TERMINATED

Trial details

NCT number: NCT00467610
Sponsor: Rush University Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2007-05-01
Primary completion: 2008-12-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.